Thilo Zander
ORCID: 0000-0003-3691-7497Also affiliated with University of South Florida, Luzerner Kantonsspital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)”.
Martin Fehr, Sämi Schär, Martin Dreyling, Christian Schmidt, Enrico Derenzini +19 more
Maria Cristina Pirosa, Sämi Schär, Marianne Brodtkorb, Björn E. Wahlin, Micaela Hernberg +19 more
Michelle A. Kendall, Thilo Zander, Joseph Sujka, P.C. Kuo, Mark S. Baker +1 more